OptiBiotix Health PLC (LON:OPTI) has signed a distributor agreement with Advanced NutriSolutions Inc./Select Ingredient covering the United States and Canada.
Under the terms of the agreement, Advanced NutriSolutions Inc./Select Ingredient will supply OptiBiotix's cholesterol and blood pressure-reducing probiotic strain Lactobacillus plantarum LPLDL, under an exclusive licence, to customers in the United States and Canada for inclusion into dietary supplements formulation.
Advanced NutriSolutions Inc./Select Ingredient supplies nutritional ingredients, contract manufacturing services, and finished products to the nutritional supplement industry.
Steve Prescott, the chief executive of ProBiotix, a wholly-owned subsidiary of OptiBiotix, said the agreement would expand LPLDL's reach and service level in the United States and Canada.
“Advanced NutriSolutions Inc./Select Ingredient was chosen as our partner in this important region because of their technical expertise in functional ingredients including probiotics, their industry reputation, and their manufacturing capabilities which allows them not only to sell LPLDL as an ingredient but to also create custom formulation and products for customers,” Prescott said.